nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—ABCC1—Zoledronate—osteoporosis	0.313	0.443	CbGbCtD
Idarubicin—ABCC1—Conjugated Estrogens—osteoporosis	0.174	0.246	CbGbCtD
Idarubicin—CYP2C9—Estropipate—osteoporosis	0.0916	0.129	CbGbCtD
Idarubicin—CYP2C9—Cholecalciferol—osteoporosis	0.0472	0.0667	CbGbCtD
Idarubicin—CYP2D6—Cholecalciferol—osteoporosis	0.0432	0.061	CbGbCtD
Idarubicin—CYP2C9—Estradiol—osteoporosis	0.038	0.0538	CbGbCtD
Idarubicin—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.00162	0.337	CbGdCrCtD
Idarubicin—TOP2A—Levorphanol—Estradiol—osteoporosis	0.00107	0.222	CbGdCrCtD
Idarubicin—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.000978	0.203	CbGdCrCtD
Idarubicin—Urethral disorder—Risedronate—osteoporosis	0.000638	0.00222	CcSEcCtD
Idarubicin—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000637	0.132	CbGdCrCtD
Idarubicin—Anaemia—Ibandronate—osteoporosis	0.000635	0.00221	CcSEcCtD
Idarubicin—Haemoglobin—Pamidronate—osteoporosis	0.000622	0.00216	CcSEcCtD
Idarubicin—Haemorrhage—Pamidronate—osteoporosis	0.000619	0.00215	CcSEcCtD
Idarubicin—Stomatitis—Zoledronate—osteoporosis	0.000614	0.00213	CcSEcCtD
Idarubicin—Nausea—Calcium Acetate—osteoporosis	0.000612	0.00213	CcSEcCtD
Idarubicin—Urinary tract disorder—Pamidronate—osteoporosis	0.000611	0.00212	CcSEcCtD
Idarubicin—Urethral disorder—Pamidronate—osteoporosis	0.000606	0.00211	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000606	0.00211	CcSEcCtD
Idarubicin—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000606	0.00211	CcSEcCtD
Idarubicin—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.000603	0.0021	CcSEcCtD
Idarubicin—Chest pain—Alendronate—osteoporosis	0.000601	0.00209	CcSEcCtD
Idarubicin—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000597	0.00208	CcSEcCtD
Idarubicin—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000594	0.00207	CcSEcCtD
Idarubicin—Chest pain—Raloxifene—osteoporosis	0.000591	0.00206	CcSEcCtD
Idarubicin—Angiopathy—Risedronate—osteoporosis	0.00059	0.00205	CcSEcCtD
Idarubicin—Alopecia—Ethinyl Estradiol—osteoporosis	0.00059	0.00205	CcSEcCtD
Idarubicin—Immune system disorder—Risedronate—osteoporosis	0.000588	0.00204	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000587	0.00204	CcSEcCtD
Idarubicin—Chest pain—Ibandronate—osteoporosis	0.000585	0.00204	CcSEcCtD
Idarubicin—Anaphylactic shock—Estropipate—osteoporosis	0.000585	0.00203	CcSEcCtD
Idarubicin—Convulsion—Calcitriol—osteoporosis	0.000583	0.00203	CcSEcCtD
Idarubicin—Arrhythmia—Risedronate—osteoporosis	0.000581	0.00202	CcSEcCtD
Idarubicin—Infection—Estropipate—osteoporosis	0.000581	0.00202	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000581	0.00202	CcSEcCtD
Idarubicin—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000581	0.00202	CcSEcCtD
Idarubicin—Flushing—Pamidronate—osteoporosis	0.000574	0.002	CcSEcCtD
Idarubicin—Chest pain—Calcitriol—osteoporosis	0.000573	0.00199	CcSEcCtD
Idarubicin—Infection—Alendronate—osteoporosis	0.000572	0.00199	CcSEcCtD
Idarubicin—Skin disorder—Estropipate—osteoporosis	0.000568	0.00198	CcSEcCtD
Idarubicin—Malnutrition—Risedronate—osteoporosis	0.000567	0.00197	CcSEcCtD
Idarubicin—Infection—Raloxifene—osteoporosis	0.000563	0.00196	CcSEcCtD
Idarubicin—Angiopathy—Pamidronate—osteoporosis	0.000561	0.00195	CcSEcCtD
Idarubicin—Anaphylactic shock—Ibandronate—osteoporosis	0.000561	0.00195	CcSEcCtD
Idarubicin—Immune system disorder—Pamidronate—osteoporosis	0.000559	0.00194	CcSEcCtD
Idarubicin—Urinary tract disorder—Zoledronate—osteoporosis	0.000558	0.00194	CcSEcCtD
Idarubicin—Shock—Raloxifene—osteoporosis	0.000558	0.00194	CcSEcCtD
Idarubicin—Infection—Ibandronate—osteoporosis	0.000557	0.00194	CcSEcCtD
Idarubicin—Chills—Pamidronate—osteoporosis	0.000555	0.00193	CcSEcCtD
Idarubicin—Thrombocytopenia—Raloxifene—osteoporosis	0.000555	0.00193	CcSEcCtD
Idarubicin—Urethral disorder—Zoledronate—osteoporosis	0.000554	0.00193	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000553	0.00192	CcSEcCtD
Idarubicin—Shock—Ibandronate—osteoporosis	0.000552	0.00192	CcSEcCtD
Idarubicin—Skin disorder—Raloxifene—osteoporosis	0.00055	0.00191	CcSEcCtD
Idarubicin—Anaphylactic shock—Calcitriol—osteoporosis	0.000549	0.00191	CcSEcCtD
Idarubicin—Alopecia—Pamidronate—osteoporosis	0.000547	0.0019	CcSEcCtD
Idarubicin—Skin disorder—Ibandronate—osteoporosis	0.000545	0.0019	CcSEcCtD
Idarubicin—Nausea—Ergocalciferol—osteoporosis	0.00054	0.00188	CcSEcCtD
Idarubicin—Malnutrition—Pamidronate—osteoporosis	0.000539	0.00187	CcSEcCtD
Idarubicin—Urticaria—Etidronic acid—osteoporosis	0.000537	0.00187	CcSEcCtD
Idarubicin—Abdominal pain—Etidronic acid—osteoporosis	0.000535	0.00186	CcSEcCtD
Idarubicin—Skin disorder—Calcitriol—osteoporosis	0.000533	0.00186	CcSEcCtD
Idarubicin—Flushing—Zoledronate—osteoporosis	0.000524	0.00182	CcSEcCtD
Idarubicin—Anaemia—Risedronate—osteoporosis	0.000524	0.00182	CcSEcCtD
Idarubicin—Anorexia—Calcitriol—osteoporosis	0.000523	0.00182	CcSEcCtD
Idarubicin—Angiopathy—Zoledronate—osteoporosis	0.000513	0.00178	CcSEcCtD
Idarubicin—Immune system disorder—Zoledronate—osteoporosis	0.00051	0.00178	CcSEcCtD
Idarubicin—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000507	0.105	CbGdCrCtD
Idarubicin—Chills—Zoledronate—osteoporosis	0.000507	0.00176	CcSEcCtD
Idarubicin—Arrhythmia—Zoledronate—osteoporosis	0.000505	0.00176	CcSEcCtD
Idarubicin—Alopecia—Zoledronate—osteoporosis	0.000499	0.00174	CcSEcCtD
Idarubicin—Hypersensitivity—Etidronic acid—osteoporosis	0.000498	0.00173	CcSEcCtD
Idarubicin—Anaemia—Pamidronate—osteoporosis	0.000498	0.00173	CcSEcCtD
Idarubicin—Angiopathy—Conjugated Estrogens—osteoporosis	0.000494	0.00172	CcSEcCtD
Idarubicin—Malnutrition—Zoledronate—osteoporosis	0.000492	0.00171	CcSEcCtD
Idarubicin—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000491	0.00171	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000491	0.00171	CcSEcCtD
Idarubicin—Decreased appetite—Ibandronate—osteoporosis	0.000488	0.0017	CcSEcCtD
Idarubicin—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000486	0.00169	CcSEcCtD
Idarubicin—Chest pain—Risedronate—osteoporosis	0.000482	0.00168	CcSEcCtD
Idarubicin—Leukopenia—Pamidronate—osteoporosis	0.000482	0.00168	CcSEcCtD
Idarubicin—Alopecia—Conjugated Estrogens—osteoporosis	0.000481	0.00167	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000479	0.00167	CcSEcCtD
Idarubicin—Gastrointestinal pain—Estropipate—osteoporosis	0.000478	0.00166	CcSEcCtD
Idarubicin—Acute coronary syndrome—Estradiol—osteoporosis	0.000478	0.00166	CcSEcCtD
Idarubicin—Decreased appetite—Calcitriol—osteoporosis	0.000477	0.00166	CcSEcCtD
Idarubicin—Myocardial infarction—Estradiol—osteoporosis	0.000475	0.00165	CcSEcCtD
Idarubicin—Malnutrition—Conjugated Estrogens—osteoporosis	0.000474	0.00165	CcSEcCtD
Idarubicin—Gastrointestinal pain—Alendronate—osteoporosis	0.000471	0.00164	CcSEcCtD
Idarubicin—Infection—Ethinyl Estradiol—osteoporosis	0.000471	0.00164	CcSEcCtD
Idarubicin—Convulsion—Pamidronate—osteoporosis	0.000467	0.00162	CcSEcCtD
Idarubicin—Urticaria—Estropipate—osteoporosis	0.000465	0.00162	CcSEcCtD
Idarubicin—Gastrointestinal pain—Raloxifene—osteoporosis	0.000463	0.00161	CcSEcCtD
Idarubicin—Diarrhoea—Etidronic acid—osteoporosis	0.000463	0.00161	CcSEcCtD
Idarubicin—Abdominal pain—Estropipate—osteoporosis	0.000462	0.00161	CcSEcCtD
Idarubicin—Body temperature increased—Estropipate—osteoporosis	0.000462	0.00161	CcSEcCtD
Idarubicin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000461	0.0016	CcSEcCtD
Idarubicin—Infection—Risedronate—osteoporosis	0.000459	0.0016	CcSEcCtD
Idarubicin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000459	0.0016	CcSEcCtD
Idarubicin—Urticaria—Alendronate—osteoporosis	0.000458	0.00159	CcSEcCtD
Idarubicin—Abdominal pain—Alendronate—osteoporosis	0.000456	0.00158	CcSEcCtD
Idarubicin—Body temperature increased—Alendronate—osteoporosis	0.000456	0.00158	CcSEcCtD
Idarubicin—Shock—Risedronate—osteoporosis	0.000455	0.00158	CcSEcCtD
Idarubicin—Anaemia—Zoledronate—osteoporosis	0.000455	0.00158	CcSEcCtD
Idarubicin—Skin disorder—Risedronate—osteoporosis	0.000449	0.00156	CcSEcCtD
Idarubicin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000449	0.00156	CcSEcCtD
Idarubicin—Abdominal pain—Raloxifene—osteoporosis	0.000448	0.00156	CcSEcCtD
Idarubicin—Body temperature increased—Raloxifene—osteoporosis	0.000448	0.00156	CcSEcCtD
Idarubicin—Urticaria—Ibandronate—osteoporosis	0.000446	0.00155	CcSEcCtD
Idarubicin—Abdominal pain—Ibandronate—osteoporosis	0.000443	0.00154	CcSEcCtD
Idarubicin—Body temperature increased—Ibandronate—osteoporosis	0.000443	0.00154	CcSEcCtD
Idarubicin—Leukopenia—Zoledronate—osteoporosis	0.00044	0.00153	CcSEcCtD
Idarubicin—Anaphylactic shock—Pamidronate—osteoporosis	0.00044	0.00153	CcSEcCtD
Idarubicin—Haemoglobin—Estradiol—osteoporosis	0.000438	0.00152	CcSEcCtD
Idarubicin—Infection—Pamidronate—osteoporosis	0.000437	0.00152	CcSEcCtD
Idarubicin—Urticaria—Calcitriol—osteoporosis	0.000436	0.00152	CcSEcCtD
Idarubicin—Haemorrhage—Estradiol—osteoporosis	0.000435	0.00151	CcSEcCtD
Idarubicin—Body temperature increased—Calcitriol—osteoporosis	0.000434	0.00151	CcSEcCtD
Idarubicin—Abdominal pain—Calcitriol—osteoporosis	0.000434	0.00151	CcSEcCtD
Idarubicin—Shock—Pamidronate—osteoporosis	0.000432	0.0015	CcSEcCtD
Idarubicin—Hypersensitivity—Estropipate—osteoporosis	0.000431	0.0015	CcSEcCtD
Idarubicin—Thrombocytopenia—Pamidronate—osteoporosis	0.00043	0.0015	CcSEcCtD
Idarubicin—Urinary tract disorder—Estradiol—osteoporosis	0.00043	0.0015	CcSEcCtD
Idarubicin—Vomiting—Etidronic acid—osteoporosis	0.00043	0.0015	CcSEcCtD
Idarubicin—Urethral disorder—Estradiol—osteoporosis	0.000427	0.00148	CcSEcCtD
Idarubicin—Rash—Etidronic acid—osteoporosis	0.000426	0.00148	CcSEcCtD
Idarubicin—Convulsion—Zoledronate—osteoporosis	0.000426	0.00148	CcSEcCtD
Idarubicin—Dermatitis—Etidronic acid—osteoporosis	0.000426	0.00148	CcSEcCtD
Idarubicin—Hypersensitivity—Alendronate—osteoporosis	0.000425	0.00148	CcSEcCtD
Idarubicin—Headache—Etidronic acid—osteoporosis	0.000424	0.00147	CcSEcCtD
Idarubicin—Anorexia—Pamidronate—osteoporosis	0.000419	0.00146	CcSEcCtD
Idarubicin—Chest pain—Zoledronate—osteoporosis	0.000419	0.00146	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000416	0.00145	CcSEcCtD
Idarubicin—Hypersensitivity—Ibandronate—osteoporosis	0.000413	0.00144	CcSEcCtD
Idarubicin—Convulsion—Conjugated Estrogens—osteoporosis	0.00041	0.00143	CcSEcCtD
Idarubicin—Hypersensitivity—Calcitriol—osteoporosis	0.000405	0.00141	CcSEcCtD
Idarubicin—Flushing—Estradiol—osteoporosis	0.000404	0.00141	CcSEcCtD
Idarubicin—Chest pain—Conjugated Estrogens—osteoporosis	0.000403	0.0014	CcSEcCtD
Idarubicin—Nausea—Etidronic acid—osteoporosis	0.000402	0.0014	CcSEcCtD
Idarubicin—Anaphylactic shock—Zoledronate—osteoporosis	0.000401	0.0014	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.0004	0.00139	CcSEcCtD
Idarubicin—Diarrhoea—Estropipate—osteoporosis	0.0004	0.00139	CcSEcCtD
Idarubicin—Infection—Zoledronate—osteoporosis	0.000399	0.00139	CcSEcCtD
Idarubicin—Angiopathy—Estradiol—osteoporosis	0.000395	0.00137	CcSEcCtD
Idarubicin—Shock—Zoledronate—osteoporosis	0.000395	0.00137	CcSEcCtD
Idarubicin—Diarrhoea—Alendronate—osteoporosis	0.000394	0.00137	CcSEcCtD
Idarubicin—Immune system disorder—Estradiol—osteoporosis	0.000393	0.00137	CcSEcCtD
Idarubicin—Thrombocytopenia—Zoledronate—osteoporosis	0.000393	0.00137	CcSEcCtD
Idarubicin—Chills—Estradiol—osteoporosis	0.000391	0.00136	CcSEcCtD
Idarubicin—Skin disorder—Zoledronate—osteoporosis	0.00039	0.00136	CcSEcCtD
Idarubicin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000388	0.00135	CcSEcCtD
Idarubicin—Diarrhoea—Raloxifene—osteoporosis	0.000388	0.00135	CcSEcCtD
Idarubicin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000387	0.00134	CcSEcCtD
Idarubicin—Alopecia—Estradiol—osteoporosis	0.000385	0.00134	CcSEcCtD
Idarubicin—Infection—Conjugated Estrogens—osteoporosis	0.000384	0.00134	CcSEcCtD
Idarubicin—Diarrhoea—Ibandronate—osteoporosis	0.000384	0.00134	CcSEcCtD
Idarubicin—Anorexia—Zoledronate—osteoporosis	0.000383	0.00133	CcSEcCtD
Idarubicin—Decreased appetite—Pamidronate—osteoporosis	0.000382	0.00133	CcSEcCtD
Idarubicin—Shock—Conjugated Estrogens—osteoporosis	0.00038	0.00132	CcSEcCtD
Idarubicin—Malnutrition—Estradiol—osteoporosis	0.000379	0.00132	CcSEcCtD
Idarubicin—Gastrointestinal pain—Risedronate—osteoporosis	0.000378	0.00131	CcSEcCtD
Idarubicin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000377	0.00131	CcSEcCtD
Idarubicin—Diarrhoea—Calcitriol—osteoporosis	0.000376	0.00131	CcSEcCtD
Idarubicin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000375	0.00131	CcSEcCtD
Idarubicin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000375	0.0013	CcSEcCtD
Idarubicin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000375	0.0013	CcSEcCtD
Idarubicin—Vomiting—Estropipate—osteoporosis	0.000372	0.00129	CcSEcCtD
Idarubicin—Rash—Estropipate—osteoporosis	0.000369	0.00128	CcSEcCtD
Idarubicin—Dermatitis—Estropipate—osteoporosis	0.000369	0.00128	CcSEcCtD
Idarubicin—Anorexia—Conjugated Estrogens—osteoporosis	0.000368	0.00128	CcSEcCtD
Idarubicin—Urticaria—Risedronate—osteoporosis	0.000367	0.00128	CcSEcCtD
Idarubicin—Headache—Estropipate—osteoporosis	0.000367	0.00127	CcSEcCtD
Idarubicin—Vomiting—Alendronate—osteoporosis	0.000366	0.00127	CcSEcCtD
Idarubicin—Abdominal pain—Risedronate—osteoporosis	0.000365	0.00127	CcSEcCtD
Idarubicin—Body temperature increased—Risedronate—osteoporosis	0.000365	0.00127	CcSEcCtD
Idarubicin—Rash—Alendronate—osteoporosis	0.000363	0.00126	CcSEcCtD
Idarubicin—Dermatitis—Alendronate—osteoporosis	0.000363	0.00126	CcSEcCtD
Idarubicin—Headache—Alendronate—osteoporosis	0.000361	0.00126	CcSEcCtD
Idarubicin—Vomiting—Raloxifene—osteoporosis	0.00036	0.00125	CcSEcCtD
Idarubicin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000359	0.00125	CcSEcCtD
Idarubicin—Rash—Raloxifene—osteoporosis	0.000357	0.00124	CcSEcCtD
Idarubicin—Dermatitis—Raloxifene—osteoporosis	0.000357	0.00124	CcSEcCtD
Idarubicin—Vomiting—Ibandronate—osteoporosis	0.000357	0.00124	CcSEcCtD
Idarubicin—Headache—Raloxifene—osteoporosis	0.000355	0.00123	CcSEcCtD
Idarubicin—Rash—Ibandronate—osteoporosis	0.000354	0.00123	CcSEcCtD
Idarubicin—Dermatitis—Ibandronate—osteoporosis	0.000353	0.00123	CcSEcCtD
Idarubicin—Headache—Ibandronate—osteoporosis	0.000351	0.00122	CcSEcCtD
Idarubicin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000349	0.00122	CcSEcCtD
Idarubicin—Vomiting—Calcitriol—osteoporosis	0.000349	0.00121	CcSEcCtD
Idarubicin—Decreased appetite—Zoledronate—osteoporosis	0.000349	0.00121	CcSEcCtD
Idarubicin—Nausea—Estropipate—osteoporosis	0.000348	0.00121	CcSEcCtD
Idarubicin—Abdominal pain—Pamidronate—osteoporosis	0.000347	0.00121	CcSEcCtD
Idarubicin—Body temperature increased—Pamidronate—osteoporosis	0.000347	0.00121	CcSEcCtD
Idarubicin—Rash—Calcitriol—osteoporosis	0.000346	0.0012	CcSEcCtD
Idarubicin—Dermatitis—Calcitriol—osteoporosis	0.000346	0.0012	CcSEcCtD
Idarubicin—Headache—Calcitriol—osteoporosis	0.000344	0.0012	CcSEcCtD
Idarubicin—Nausea—Alendronate—osteoporosis	0.000342	0.00119	CcSEcCtD
Idarubicin—Hypersensitivity—Risedronate—osteoporosis	0.000341	0.00118	CcSEcCtD
Idarubicin—Nausea—Raloxifene—osteoporosis	0.000337	0.00117	CcSEcCtD
Idarubicin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000336	0.00117	CcSEcCtD
Idarubicin—Nausea—Ibandronate—osteoporosis	0.000333	0.00116	CcSEcCtD
Idarubicin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000328	0.00114	CcSEcCtD
Idarubicin—Nausea—Calcitriol—osteoporosis	0.000326	0.00113	CcSEcCtD
Idarubicin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000324	0.00113	CcSEcCtD
Idarubicin—Hypersensitivity—Pamidronate—osteoporosis	0.000324	0.00113	CcSEcCtD
Idarubicin—Chest pain—Estradiol—osteoporosis	0.000323	0.00112	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000321	0.00111	CcSEcCtD
Idarubicin—Urticaria—Zoledronate—osteoporosis	0.000319	0.00111	CcSEcCtD
Idarubicin—Abdominal pain—Zoledronate—osteoporosis	0.000317	0.0011	CcSEcCtD
Idarubicin—Body temperature increased—Zoledronate—osteoporosis	0.000317	0.0011	CcSEcCtD
Idarubicin—Diarrhoea—Risedronate—osteoporosis	0.000316	0.0011	CcSEcCtD
Idarubicin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000316	0.0011	CcSEcCtD
Idarubicin—Anaphylactic shock—Estradiol—osteoporosis	0.000309	0.00108	CcSEcCtD
Idarubicin—Infection—Estradiol—osteoporosis	0.000307	0.00107	CcSEcCtD
Idarubicin—Urticaria—Conjugated Estrogens—osteoporosis	0.000307	0.00107	CcSEcCtD
Idarubicin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000306	0.00106	CcSEcCtD
Idarubicin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000306	0.00106	CcSEcCtD
Idarubicin—Shock—Estradiol—osteoporosis	0.000304	0.00106	CcSEcCtD
Idarubicin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000302	0.00105	CcSEcCtD
Idarubicin—Diarrhoea—Pamidronate—osteoporosis	0.000301	0.00105	CcSEcCtD
Idarubicin—Skin disorder—Estradiol—osteoporosis	0.000301	0.00105	CcSEcCtD
Idarubicin—Rash—Ethinyl Estradiol—osteoporosis	0.000299	0.00104	CcSEcCtD
Idarubicin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000299	0.00104	CcSEcCtD
Idarubicin—Headache—Ethinyl Estradiol—osteoporosis	0.000297	0.00103	CcSEcCtD
Idarubicin—Hypersensitivity—Zoledronate—osteoporosis	0.000296	0.00103	CcSEcCtD
Idarubicin—Vomiting—Risedronate—osteoporosis	0.000294	0.00102	CcSEcCtD
Idarubicin—Rash—Risedronate—osteoporosis	0.000292	0.00101	CcSEcCtD
Idarubicin—Dermatitis—Risedronate—osteoporosis	0.000291	0.00101	CcSEcCtD
Idarubicin—Headache—Risedronate—osteoporosis	0.00029	0.00101	CcSEcCtD
Idarubicin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000285	0.000991	CcSEcCtD
Idarubicin—Nausea—Ethinyl Estradiol—osteoporosis	0.000282	0.00098	CcSEcCtD
Idarubicin—Vomiting—Pamidronate—osteoporosis	0.000279	0.000972	CcSEcCtD
Idarubicin—Rash—Pamidronate—osteoporosis	0.000277	0.000964	CcSEcCtD
Idarubicin—Dermatitis—Pamidronate—osteoporosis	0.000277	0.000963	CcSEcCtD
Idarubicin—Headache—Pamidronate—osteoporosis	0.000275	0.000958	CcSEcCtD
Idarubicin—Diarrhoea—Zoledronate—osteoporosis	0.000275	0.000955	CcSEcCtD
Idarubicin—Nausea—Risedronate—osteoporosis	0.000275	0.000955	CcSEcCtD
Idarubicin—Decreased appetite—Estradiol—osteoporosis	0.000269	0.000935	CcSEcCtD
Idarubicin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000264	0.00092	CcSEcCtD
Idarubicin—Nausea—Pamidronate—osteoporosis	0.000261	0.000908	CcSEcCtD
Idarubicin—Vomiting—Zoledronate—osteoporosis	0.000255	0.000888	CcSEcCtD
Idarubicin—Rash—Zoledronate—osteoporosis	0.000253	0.00088	CcSEcCtD
Idarubicin—Gastrointestinal pain—Estradiol—osteoporosis	0.000253	0.00088	CcSEcCtD
Idarubicin—Dermatitis—Zoledronate—osteoporosis	0.000253	0.00088	CcSEcCtD
Idarubicin—Headache—Zoledronate—osteoporosis	0.000252	0.000875	CcSEcCtD
Idarubicin—Vomiting—Conjugated Estrogens—osteoporosis	0.000246	0.000855	CcSEcCtD
Idarubicin—Urticaria—Estradiol—osteoporosis	0.000246	0.000855	CcSEcCtD
Idarubicin—Body temperature increased—Estradiol—osteoporosis	0.000245	0.000851	CcSEcCtD
Idarubicin—Abdominal pain—Estradiol—osteoporosis	0.000245	0.000851	CcSEcCtD
Idarubicin—Rash—Conjugated Estrogens—osteoporosis	0.000244	0.000848	CcSEcCtD
Idarubicin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000244	0.000847	CcSEcCtD
Idarubicin—Headache—Conjugated Estrogens—osteoporosis	0.000242	0.000842	CcSEcCtD
Idarubicin—Nausea—Zoledronate—osteoporosis	0.000238	0.000829	CcSEcCtD
Idarubicin—Nausea—Conjugated Estrogens—osteoporosis	0.00023	0.000799	CcSEcCtD
Idarubicin—Hypersensitivity—Estradiol—osteoporosis	0.000228	0.000793	CcSEcCtD
Idarubicin—Diarrhoea—Estradiol—osteoporosis	0.000212	0.000736	CcSEcCtD
Idarubicin—Vomiting—Estradiol—osteoporosis	0.000197	0.000684	CcSEcCtD
Idarubicin—Rash—Estradiol—osteoporosis	0.000195	0.000678	CcSEcCtD
Idarubicin—Dermatitis—Estradiol—osteoporosis	0.000195	0.000678	CcSEcCtD
Idarubicin—Headache—Estradiol—osteoporosis	0.000194	0.000674	CcSEcCtD
Idarubicin—Nausea—Estradiol—osteoporosis	0.000184	0.000639	CcSEcCtD
